Treanda (Bendamustine)

Bendamustine Hydrochloride is a type of chemotherapy medicine. It's used to treat certain types of cancer, like leukemia and lymphoma. It works by attacking cancer cells.

Brand names:Treanda, Bendeka
Medication

What people taking Treanda (Bendamustine) report

Every report comes from a Lived member, sent anonymously.

Have you tried Treanda (Bendamustine) for Follicular Lymphoma?

NameHow it went

About Treanda (Bendamustine)

What It's For

Bendamustine is an intravenous (IV) chemotherapy drug used to treat certain blood cancers that start in B cells, a type of white blood cell. Treanda is the original brand. Bendeka is another brand of the same medicine that is infused more quickly, and generic versions are also available. In the US it is approved for two uses. The first is chronic lymphocytic leukemia (CLL), a usually slow-growing leukemia of B cells. The second is indolent (slow-growing) B-cell non-Hodgkin lymphoma that kept growing during treatment with rituximab, an antibody drug that targets B cells, or within six months after it. In practice, bendamustine is most often given together with rituximab, a pairing known as bendamustine-rituximab (BR). Cancer specialists also use BR as a first treatment for slow-growing lymphomas and for mantle cell lymphoma. These uses are well studied but fall outside the approved label. For CLL, BR is one of several first-line options. Newer targeted pills, such as Bruton tyrosine kinase (BTK) inhibitors (for example zanubrutinib) and venetoclax, are also widely used, and in a head-to-head trial zanubrutinib kept CLL under control longer than BR.

How It Works

Bendamustine belongs to a group of chemotherapy drugs called alkylating agents. It attaches to the DNA inside cells and links the two strands of the DNA together. A cell has to separate those strands to copy its DNA and divide, so this damage pushes cancer cells toward dying. Bendamustine can affect cells that are resting as well as cells that are actively dividing. Researchers still do not fully understand why it behaves differently from older drugs in the same class. The same damage reaches healthy cells, especially the bone marrow cells that constantly make new blood cells. That is why lower blood counts are its main side effect. When it is paired with rituximab, the two drugs attack B cells in different ways: rituximab attaches to a protein called CD20 on the surface of B cells and helps destroy them, while bendamustine damages their DNA.

Dosage & Administration

Bendamustine is given only in a clinic or hospital, through an IV line into a vein. Treatment runs in cycles: an infusion on two days in a row, followed by a break of several weeks so blood counts can recover before the next round. Under the label, CLL treatment uses a 28-day cycle for up to six cycles, and lymphoma treatment uses a 21-day cycle for up to eight cycles. When bendamustine is combined with rituximab, the dose and schedule can differ from these. Each Treanda infusion takes 30 to 60 minutes, while a Bendeka infusion takes about 10 minutes. The dose is calculated from body size (height and weight). It is often delayed or lowered if blood counts have not recovered or an earlier cycle caused severe side effects. Bendamustine products come in different strengths and are prepared differently, so the pharmacy prepares the specific product ordered rather than swapping one for another. The team may give medicines to prevent or treat nausea. If an earlier infusion caused a mild reaction, antihistamines, fever reducers or steroids may be given beforehand in later cycles. If you cannot make an infusion appointment, call the clinic to reschedule rather than simply skipping it.

Side Effects

Nausea and tiredness are the effects people most often notice during and in the day after an infusion. Vomiting, fever, diarrhea or constipation, poor appetite, weight loss, headache, cough, mouth sores and rash are also common, especially in lymphoma treatment. Many of these can be eased with anti-nausea medicine and other supportive care, so they are worth reporting rather than enduring. Fatigue can be strong enough that you should not drive or use dangerous machinery while it lasts. The most important effect is one you cannot feel at first. Bendamustine lowers blood counts in nearly everyone who receives it, usually reaching the lowest point in the third week of a cycle. Low white cells make infections more likely and more serious, low platelets raise the risk of bleeding and bruising, and low red cells cause tiredness and shortness of breath. Call the care team right away for a fever, chills or other signs of infection, or for unusual bleeding. Infusion reactions such as fever, chills, itching or rash are fairly common. Severe allergic reactions are rare but can happen, more often in the second or later cycles. Tell the team immediately about rash, facial swelling or trouble breathing during or soon after an infusion. If severe trouble breathing or swelling of the face or throat starts after you have left the clinic, call 911. Anyone who has had a serious allergic reaction to bendamustine should not receive it again.

Interactions & Warnings

Because bendamustine weakens the immune system, old infections can flare up again. These include hepatitis B, cytomegalovirus (CMV, a common virus that is usually harmless in healthy people), tuberculosis and shingles. The team may test for these before starting and prescribe preventive medicines. A rare but serious brain infection called progressive multifocal leukoencephalopathy (PML) has also occurred, mostly when bendamustine was given with rituximab or obinutuzumab (another antibody drug that targets B cells). Contact the care team right away about new confusion, memory loss, trouble speaking or walking, or vision loss. In the first cycle, cancer cells can break down so quickly that their contents overload the kidneys, a problem called tumor lysis syndrome. People at higher risk get extra fluids and blood tests, and sometimes allopurinol, a medicine that lowers uric acid. Allopurinol may raise the risk of severe skin reactions with bendamustine, and these reactions can also happen without it. Report a severe or worsening rash, blistering or peeling skin right away. Liver injury can occur too, mostly in the first three months, so yellowing of the skin or eyes is a reason to call promptly. Some medicines change how the body clears bendamustine. The antibiotic ciprofloxacin and the antidepressant fluvoxamine can raise its levels and side effects, and smoking can make it less effective. Bendamustine is not used in people with severe kidney impairment or moderate to severe liver impairment. Bendamustine can harm a developing baby, and a pregnancy test is recommended before starting. Women who could become pregnant should use effective birth control during treatment and for 6 months after the last dose. Men with partners who could become pregnant should do the same for 3 months after the last dose. Breastfeeding is not recommended during treatment or for 1 week afterward. Bendamustine may also reduce male fertility, sometimes for years or permanently.

What to Expect

A full course usually takes about six months, most of it spent between infusions. Blood counts are checked often, and liver tests are done before and during treatment. The team uses these results to decide whether each cycle can go ahead on schedule or needs a delay or a lower dose. Changes to the plan are common and are not in themselves a sign that treatment is failing. Response is judged with exams, blood tests and scans during and after the course. In the study that led to approval for lymphoma that had stopped responding to rituximab, about three in four people had their cancer shrink, and that response lasted a median of about nine months. As a first treatment for slow-growing lymphoma, BR held the disease in check longer than R-CHOP, an older combination of rituximab with four chemotherapy and steroid drugs, and caused fewer toxic effects, although people did not live longer on average. Whether more treatment is needed later depends on the type of cancer and how it responds. Second cancers, including skin cancers and bone marrow disorders, have been reported in people treated with bendamustine. Regular skin checks during and after treatment are recommended, and any new or changing skin spot is worth showing to the care team.

Questions to Ask Your Doctor

  1. 1.Why is bendamustine, with or without rituximab, a good choice for my cancer compared with targeted pills or other chemotherapy combinations?
  2. 2.How many cycles do you expect me to need, and how will we know whether it is working?
  3. 3.Will I be tested for hepatitis B or other infections first, and will I take preventive medicines during treatment?
  4. 4.Who should I call if I get a fever or feel unwell between infusions, including at night or on weekends?
  5. 5.How could treatment affect my fertility, and should I consider preserving sperm or other options before starting?

Last reviewed • Oct 2026

Educational content, not medical advice.